![Upfront Next-Generation Sequencing for Lung Cancer Patients Saves Time, Money](https://www.g2intelligence.com/wp-content/uploads/2023/04/56181_G2_stock_8-1080x675.jpg)
Upfront Next-Generation Sequencing for Lung Cancer Patients Saves Time, Money
From - Diagnostic Testing & Emerging Technologies
Use of upfront next-generation sequencing (NGS) testing at diagnosis of patients with metastatic non-small-cell lung cancer (mNSCLC) is…